Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2012
03/27/2012CA2230029C Multi-subtype fiv vaccines
03/22/2012WO2012037498A2 Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo
03/22/2012WO2012037485A2 Methods of inhibiting alphavirus replication and treating alphavirus infection
03/22/2012WO2012037259A1 Novel inhibitors of hepatitis c virus replication
03/22/2012WO2012037078A2 Immunogenic respiratory syncytial virus glycoprotein-containing vlps and related compositions, constructs, and therapeutic methods
03/22/2012WO2012037038A1 2' -fluoro substituted carba-nucleoside analogs for antiviral treatment
03/22/2012WO2012036616A1 Treatment of fungal infections
03/22/2012WO2012036585A1 Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same
03/22/2012WO2012036523A2 Novel antibiotically active compound and an antibiotic composition comprising the compound
03/22/2012WO2012036520A2 Novel antibiotically active compound and an antibiotic composition comprising the compound
03/22/2012WO2012036518A2 Novel antibiotically active compound and an antibiotic composition comprising the compound
03/22/2012WO2012036507A2 Aptazyme specifically releasing antisense against microrna in hcv-infected cells, and use thereof
03/22/2012WO2012036437A2 Immunogenic peptide and composition having the peptide for preventing or treating hpv-related disease
03/22/2012WO2012036215A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method
03/22/2012WO2012035519A1 Immunogenic compositions
03/22/2012WO2012035489A1 Use of derivatives of pentaphyrine as antimicrobial and desinfectant agents
03/22/2012WO2012035321A1 Methods, compounds and compositions relating to activating a latent virus
03/22/2012WO2012035305A1 Bioactive alkaloids
03/22/2012WO2012035147A1 Nuclear export inhibitors
03/22/2012WO2012035082A1 Primulae flos flower extract for the treatment and prophylaxis of inflammations or viral infections
03/22/2012WO2012035028A1 Compositions for the vaginal and oral administration of lactobacillus and uses thereof
03/22/2012WO2012034719A1 Novel antiviral acyclic nucleoside phosphonates
03/22/2012WO2012013366A3 Preventive bactericidal polish for nail treatment
03/22/2012WO2011133712A3 Anti-viral compounds
03/22/2012WO2011130557A3 Phosphonates with reduced toxicity for treatment of viral infections
03/22/2012WO2011120474A9 Method for inhibiting hiv replication in mammal and human cells
03/22/2012US20120071859 Inducible interleukin-12
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071545 Compositions and methods for treatment of bacterial and mycobacterial infections
03/22/2012US20120071539 Compounds and methods for modulating the silencing of a polynucleotide of interest
03/22/2012US20120071533 Anti-fungal formulation
03/22/2012US20120071531 Use of Fungicides for the Treatment of Fish Mycoses
03/22/2012US20120071523 Benzofuran-4,5-diones as selective peptide deformylase inhibitors
03/22/2012US20120071518 Treatment of Sepsis with 5-Ethyl-1-Phenyl-2(1H)-Pyridone
03/22/2012US20120071509 process
03/22/2012US20120071504 Modulators of cystic fibrosis transmembrane conductance regulator
03/22/2012US20120071501 Use of extracts of the genus cimicifuga as organoselective medicines for treating diseases of the genitourinary tract caused by sex hormones
03/22/2012US20120071498 Therapeutic composition to treat lesions caused by herpes simplex virus
03/22/2012US20120071477 Cdki pathway inhibitors and uses thereof
03/22/2012US20120071472 Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity
03/22/2012US20120071457 Metallo-beta-lactamase inhibitors
03/22/2012US20120071456 Composition
03/22/2012US20120071449 Pharmaceutical composition for inhalation
03/22/2012US20120071447 Antiviral Drugs for Treatment of Arenavirus Infection
03/22/2012US20120071443 Nanoparticles
03/22/2012US20120071436 Method, composition and kit for antigenic binding of norwalk-like viruses
03/22/2012US20120071434 Substituted nucleotide analogs
03/22/2012US20120071431 Platycodin Radix Extracts, and Their Use in Treating Disease Conditions Associated with Angiogenesis
03/22/2012US20120071430 Synthetic analogs of bacterial quorum sensors
03/22/2012US20120071429 Novel antibacterial agents
03/22/2012US20120071420 Modified t cell receptors and related materials and methods
03/22/2012US20120071410 Calcitonin products and therapies for treating inflammatory or degenerative diseases
03/22/2012US20120071398 Anti-microbial peptides
03/22/2012US20120071397 Methods for Hematopoietic Stem Cell Transplantation
03/22/2012US20120071394 Novel polypeptides and use thereof
03/22/2012US20120071393 Mutant CyaA Polypeptides and Polypeptide Derivatives Suitable for the Delivery of Immunogenic Molecules Into a Cell
03/22/2012US20120070510 Wound and mucous membrane disinfectant
03/22/2012US20120070493 Targeted multi-epitope dosage forms for induction of an immune response to antigens
03/22/2012US20120070489 Combination therapy for treatment of fiv infection
03/22/2012US20120070488 Method of inducing neutralizing antibodies to human immunodeficiency virus
03/22/2012US20120070485 method for producing a device applicable to biological tissues, particularly a patch for treating damaged tissues, and a device obtained by said method
03/22/2012US20120070480 Antimicrobial disposable absorbent articles
03/22/2012US20120070476 Compositions and Methods for Inactivation of Pathogens at Genital Tract Surfaces
03/22/2012US20120070467 Ophthalmic Drug Delivery
03/22/2012US20120070460 Dendritic cell modulatory molecule
03/22/2012US20120070459 Method for keeping a foot-and-mouth disease vaccine available for emergency vaccination
03/22/2012US20120070458 Adjuvanting meningococcal factor h binding protein
03/22/2012US20120070457 Polypeptides from neisseria meningitidis
03/22/2012US20120070456 Polypeptide carrier protein
03/22/2012US20120070455 Influenza vaccine
03/22/2012US20120070454 Dengue vaccine, pharmaceutical composition comprising the same, nucleotide sequence and antibody composition
03/22/2012US20120070449 Methods of treating inflammation
03/22/2012US20120070447 Methods of administering / dosing anti-rsv antibodies for prophylaxis and treatment
03/22/2012US20120070446 Rsv specific binding molecule
03/22/2012US20120070444 IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS
03/22/2012US20120070435 Chimeric antigens for eliciting an immune response
03/22/2012US20120070429 Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof
03/22/2012US20120070427 Vortex-induced silk fibroin gelation for encapsulation and delivery
03/22/2012US20120070424 Mutations on OAS1 Genes
03/22/2012US20120070423 Oral composition and method of forming and using same
03/22/2012US20120070417 Anti-influenza formulations and methods
03/22/2012US20120070416 Macrocyclic Proline Derived HCV Serine Protease Inhibitors
03/22/2012US20120070415 Azido nucleosides and nucleotide analogs
03/22/2012US20120070414 Controlling disease vectors from insects and arthropods using preconidial mycelium and extracts of preconidial mycelium from entomopathogenic fungi
03/22/2012US20120070412 HCV Inhibitor and Therapeutic Agent Combinations
03/22/2012US20120070411 Substituted nucleotide analogs
03/22/2012US20120070410 Imidazolothiazole compounds and methods of use thereof
03/22/2012US20120070409 Tetracyclic fused heterocyclic compound and use thereof as hcv polymerase inhibitor
03/22/2012US20120070401 Composition and Method for Promoting Wound Healing
03/22/2012US20120070390 Topical drug delivery system with dual carriers
03/22/2012US20120070384 Topical antifungal composition
03/22/2012US20120070377 Compounds and biological materials and uses thereof
03/22/2012US20120070370 Spiro 1,3,4-thiadiazoline derivatives as ksp inhibitors
03/22/2012CA2811501A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method
03/22/2012CA2811305A1 Immunogenic compositions
03/22/2012CA2810702A1 Inhibitors of viral entry into mammalian cells
03/22/2012CA2810524A1 Pharmaceutical compositions
03/22/2012CA2809793A1 Treatment of fungal infections
03/22/2012CA2809398A1 Compositions for the vaginal and oral administration of lactobacillus and uses thereof
03/22/2012CA2807584A1 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
1 ... 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 ... 1798